Novo Nordisk NOVO.B-0.54%decrease; red down pointing triangle said it would take over a drug under development to treat rare blood and kidney disorders from Nasdaq-listed biopharmaceutical firm Omeros ...

Dom Toretto may live his life a quarter mile at a time, but you know who doesn't? Drivers in the NHRA's Top Fuel and Funny Car classes. Organized drag racing has been around since at least the late ...

Emergency crews responded to N Hearne Avenue between Aero Drive and Shreveport Blanchard Highway. Officials with the Shreveport Police Department say a fisherman called 911 saying they saw a body out ...

It appears problems at Novo Nordisk’s recently acquired manufacturing facility in Indiana aren’t going to be solved any time soon. The FDA has tagged the former Catalent facility with an official ...

A person is in custody after a nearly 70-mile chase from Warsaw ended in Wake County early Monday morning. Officers on scene told WRAL News Warsaw police attempted to stop the driver. The driver ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. A troubled Indiana ...

(Reuters) -Novo Nordisk has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday. Bloomberg News first reported on ...

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...

Novo Nordisk A/S agreed to buy Akero Therapeutics Inc. for as much as $5.2 billion to expand its portfolio in a type of liver disease that’s linked to obesity. Novo will pay $54 a share in cash, ...

Novo Nordisk A/S (NYSE:NVO) is down 1% to trade at $59 this morning, after news surfaced that the pharmaceutical concern has entered an agreement to purchase U.S.-based peer Akero Therapeutics Inc ...

Novo Nordisk has struck a deal to buy Akero Therapeutics for up to $5.2 billion, teeing up a showdown with Roche and others in a blockbuster liver disease market. Akero confirmed its status as a key ...

C2 Racing Stable, Gary Barber, and La Milagrosa Stable's White Abarrio breezed a half-mile in company Oct. 9 at Gulfstream Park in preparation for a planned start in the $1 million Breeders' Cup Dirt ...